Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment

Long-acting, slow-release injectable fluocinolone intravitreal implants have been approved for the treatment of non-infectious uveitis affecting the posterior segment. We summarise the development of intravitreal fluocinolone implants and discuss the technology including pharmacokinetics. We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Steeples, Laura R, Pockar, Sasa, Jones, Nicholas P, Leal, Inês
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039205/
https://www.ncbi.nlm.nih.gov/pubmed/33854297
http://dx.doi.org/10.2147/OPTH.S216912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039205/
https://www.ncbi.nlm.nih.gov/pubmed/33854297
http://dx.doi.org/10.2147/OPTH.S216912

Ejemplares similares